Barriers and facilitators to the transplant process among patients living with polycystic kidney disease: a qualitative Approach
Background Kidney transplant is the gold standard for renal replacement therapy in patients with autosomal dominant polycystic kidney disease (ADPKD), which is the fourth leading cause of kidney failure. Despite the medical and economic benefits of preemptive kidney transplant over dialysis before t...
Uložené v:
| Vydané v: | BMC nephrology Ročník 24; číslo 1; s. 119 - 11 |
|---|---|
| Hlavní autori: | , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
London
BioMed Central
01.05.2023
BioMed Central Ltd Springer Nature B.V BMC |
| Predmet: | |
| ISSN: | 1471-2369, 1471-2369 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Background
Kidney transplant is the gold standard for renal replacement therapy in patients with autosomal dominant polycystic kidney disease (ADPKD), which is the fourth leading cause of kidney failure. Despite the medical and economic benefits of preemptive kidney transplant over dialysis before transplant, only 9–21% of qualifying patients receive preemptive transplants. Given the low rates of preemptive transplant, the aim of this study was to determine perceived facilitators and barriers to preemptive transplant among ADPKD patients using a qualitative approach.
Methods
Data were collected between July 2021 and January 2022 from virtual individual semi-structured interviews of 16 adult participants with ADPKD. Qualitative analysis of the recorded interviews was conducted to generate themes.
Results
Our findings revealed two themes specific for facilitators to preemptive transplant (social support and patient agency) and three themes specific to barriers for preemptive transplant (inadequate social support, gaps in knowledge, and institutional and systemic policies). The results also include various subthemes and the application of these themes to the social ecological model.
Conclusions
These findings suggest that increasing social support and patient agency, such as through patient navigator programs and encouraging effective communication between health care providers and patients, can facilitate the transplant process. Increasing dissemination of transplant knowledge from institutions and systems to patients through paired kidney exchange education and live donor outreach can also increase timely access to preemptive kidney transplants for patients with ADPKD. Our findings are limited by our single site study in the US, which may not apply to individuals experiencing different social, cultural, and health access conditions. |
|---|---|
| AbstractList | Kidney transplant is the gold standard for renal replacement therapy in patients with autosomal dominant polycystic kidney disease (ADPKD), which is the fourth leading cause of kidney failure. Despite the medical and economic benefits of preemptive kidney transplant over dialysis before transplant, only 9-21% of qualifying patients receive preemptive transplants. Given the low rates of preemptive transplant, the aim of this study was to determine perceived facilitators and barriers to preemptive transplant among ADPKD patients using a qualitative approach. Data were collected between July 2021 and January 2022 from virtual individual semi-structured interviews of 16 adult participants with ADPKD. Qualitative analysis of the recorded interviews was conducted to generate themes. Our findings revealed two themes specific for facilitators to preemptive transplant (social support and patient agency) and three themes specific to barriers for preemptive transplant (inadequate social support, gaps in knowledge, and institutional and systemic policies). The results also include various subthemes and the application of these themes to the social ecological model. These findings suggest that increasing social support and patient agency, such as through patient navigator programs and encouraging effective communication between health care providers and patients, can facilitate the transplant process. Increasing dissemination of transplant knowledge from institutions and systems to patients through paired kidney exchange education and live donor outreach can also increase timely access to preemptive kidney transplants for patients with ADPKD. Our findings are limited by our single site study in the US, which may not apply to individuals experiencing different social, cultural, and health access conditions. Abstract Background Kidney transplant is the gold standard for renal replacement therapy in patients with autosomal dominant polycystic kidney disease (ADPKD), which is the fourth leading cause of kidney failure. Despite the medical and economic benefits of preemptive kidney transplant over dialysis before transplant, only 9–21% of qualifying patients receive preemptive transplants. Given the low rates of preemptive transplant, the aim of this study was to determine perceived facilitators and barriers to preemptive transplant among ADPKD patients using a qualitative approach. Methods Data were collected between July 2021 and January 2022 from virtual individual semi-structured interviews of 16 adult participants with ADPKD. Qualitative analysis of the recorded interviews was conducted to generate themes. Results Our findings revealed two themes specific for facilitators to preemptive transplant (social support and patient agency) and three themes specific to barriers for preemptive transplant (inadequate social support, gaps in knowledge, and institutional and systemic policies). The results also include various subthemes and the application of these themes to the social ecological model. Conclusions These findings suggest that increasing social support and patient agency, such as through patient navigator programs and encouraging effective communication between health care providers and patients, can facilitate the transplant process. Increasing dissemination of transplant knowledge from institutions and systems to patients through paired kidney exchange education and live donor outreach can also increase timely access to preemptive kidney transplants for patients with ADPKD. Our findings are limited by our single site study in the US, which may not apply to individuals experiencing different social, cultural, and health access conditions. Kidney transplant is the gold standard for renal replacement therapy in patients with autosomal dominant polycystic kidney disease (ADPKD), which is the fourth leading cause of kidney failure. Despite the medical and economic benefits of preemptive kidney transplant over dialysis before transplant, only 9-21% of qualifying patients receive preemptive transplants. Given the low rates of preemptive transplant, the aim of this study was to determine perceived facilitators and barriers to preemptive transplant among ADPKD patients using a qualitative approach.BACKGROUNDKidney transplant is the gold standard for renal replacement therapy in patients with autosomal dominant polycystic kidney disease (ADPKD), which is the fourth leading cause of kidney failure. Despite the medical and economic benefits of preemptive kidney transplant over dialysis before transplant, only 9-21% of qualifying patients receive preemptive transplants. Given the low rates of preemptive transplant, the aim of this study was to determine perceived facilitators and barriers to preemptive transplant among ADPKD patients using a qualitative approach.Data were collected between July 2021 and January 2022 from virtual individual semi-structured interviews of 16 adult participants with ADPKD. Qualitative analysis of the recorded interviews was conducted to generate themes.METHODSData were collected between July 2021 and January 2022 from virtual individual semi-structured interviews of 16 adult participants with ADPKD. Qualitative analysis of the recorded interviews was conducted to generate themes.Our findings revealed two themes specific for facilitators to preemptive transplant (social support and patient agency) and three themes specific to barriers for preemptive transplant (inadequate social support, gaps in knowledge, and institutional and systemic policies). The results also include various subthemes and the application of these themes to the social ecological model.RESULTSOur findings revealed two themes specific for facilitators to preemptive transplant (social support and patient agency) and three themes specific to barriers for preemptive transplant (inadequate social support, gaps in knowledge, and institutional and systemic policies). The results also include various subthemes and the application of these themes to the social ecological model.These findings suggest that increasing social support and patient agency, such as through patient navigator programs and encouraging effective communication between health care providers and patients, can facilitate the transplant process. Increasing dissemination of transplant knowledge from institutions and systems to patients through paired kidney exchange education and live donor outreach can also increase timely access to preemptive kidney transplants for patients with ADPKD. Our findings are limited by our single site study in the US, which may not apply to individuals experiencing different social, cultural, and health access conditions.CONCLUSIONSThese findings suggest that increasing social support and patient agency, such as through patient navigator programs and encouraging effective communication between health care providers and patients, can facilitate the transplant process. Increasing dissemination of transplant knowledge from institutions and systems to patients through paired kidney exchange education and live donor outreach can also increase timely access to preemptive kidney transplants for patients with ADPKD. Our findings are limited by our single site study in the US, which may not apply to individuals experiencing different social, cultural, and health access conditions. Background Kidney transplant is the gold standard for renal replacement therapy in patients with autosomal dominant polycystic kidney disease (ADPKD), which is the fourth leading cause of kidney failure. Despite the medical and economic benefits of preemptive kidney transplant over dialysis before transplant, only 9-21% of qualifying patients receive preemptive transplants. Given the low rates of preemptive transplant, the aim of this study was to determine perceived facilitators and barriers to preemptive transplant among ADPKD patients using a qualitative approach. Methods Data were collected between July 2021 and January 2022 from virtual individual semi-structured interviews of 16 adult participants with ADPKD. Qualitative analysis of the recorded interviews was conducted to generate themes. Results Our findings revealed two themes specific for facilitators to preemptive transplant (social support and patient agency) and three themes specific to barriers for preemptive transplant (inadequate social support, gaps in knowledge, and institutional and systemic policies). The results also include various subthemes and the application of these themes to the social ecological model. Conclusions These findings suggest that increasing social support and patient agency, such as through patient navigator programs and encouraging effective communication between health care providers and patients, can facilitate the transplant process. Increasing dissemination of transplant knowledge from institutions and systems to patients through paired kidney exchange education and live donor outreach can also increase timely access to preemptive kidney transplants for patients with ADPKD. Our findings are limited by our single site study in the US, which may not apply to individuals experiencing different social, cultural, and health access conditions. Keywords: PKD, Polycystic kidney disease, ADPKD, Preemptive transplant, Kidney transplant, Transplant patient perspective Kidney transplant is the gold standard for renal replacement therapy in patients with autosomal dominant polycystic kidney disease (ADPKD), which is the fourth leading cause of kidney failure. Despite the medical and economic benefits of preemptive kidney transplant over dialysis before transplant, only 9-21% of qualifying patients receive preemptive transplants. Given the low rates of preemptive transplant, the aim of this study was to determine perceived facilitators and barriers to preemptive transplant among ADPKD patients using a qualitative approach. Data were collected between July 2021 and January 2022 from virtual individual semi-structured interviews of 16 adult participants with ADPKD. Qualitative analysis of the recorded interviews was conducted to generate themes. Our findings revealed two themes specific for facilitators to preemptive transplant (social support and patient agency) and three themes specific to barriers for preemptive transplant (inadequate social support, gaps in knowledge, and institutional and systemic policies). The results also include various subthemes and the application of these themes to the social ecological model. These findings suggest that increasing social support and patient agency, such as through patient navigator programs and encouraging effective communication between health care providers and patients, can facilitate the transplant process. Increasing dissemination of transplant knowledge from institutions and systems to patients through paired kidney exchange education and live donor outreach can also increase timely access to preemptive kidney transplants for patients with ADPKD. Our findings are limited by our single site study in the US, which may not apply to individuals experiencing different social, cultural, and health access conditions. BackgroundKidney transplant is the gold standard for renal replacement therapy in patients with autosomal dominant polycystic kidney disease (ADPKD), which is the fourth leading cause of kidney failure. Despite the medical and economic benefits of preemptive kidney transplant over dialysis before transplant, only 9–21% of qualifying patients receive preemptive transplants. Given the low rates of preemptive transplant, the aim of this study was to determine perceived facilitators and barriers to preemptive transplant among ADPKD patients using a qualitative approach.MethodsData were collected between July 2021 and January 2022 from virtual individual semi-structured interviews of 16 adult participants with ADPKD. Qualitative analysis of the recorded interviews was conducted to generate themes.ResultsOur findings revealed two themes specific for facilitators to preemptive transplant (social support and patient agency) and three themes specific to barriers for preemptive transplant (inadequate social support, gaps in knowledge, and institutional and systemic policies). The results also include various subthemes and the application of these themes to the social ecological model.ConclusionsThese findings suggest that increasing social support and patient agency, such as through patient navigator programs and encouraging effective communication between health care providers and patients, can facilitate the transplant process. Increasing dissemination of transplant knowledge from institutions and systems to patients through paired kidney exchange education and live donor outreach can also increase timely access to preemptive kidney transplants for patients with ADPKD. Our findings are limited by our single site study in the US, which may not apply to individuals experiencing different social, cultural, and health access conditions. Background Kidney transplant is the gold standard for renal replacement therapy in patients with autosomal dominant polycystic kidney disease (ADPKD), which is the fourth leading cause of kidney failure. Despite the medical and economic benefits of preemptive kidney transplant over dialysis before transplant, only 9–21% of qualifying patients receive preemptive transplants. Given the low rates of preemptive transplant, the aim of this study was to determine perceived facilitators and barriers to preemptive transplant among ADPKD patients using a qualitative approach. Methods Data were collected between July 2021 and January 2022 from virtual individual semi-structured interviews of 16 adult participants with ADPKD. Qualitative analysis of the recorded interviews was conducted to generate themes. Results Our findings revealed two themes specific for facilitators to preemptive transplant (social support and patient agency) and three themes specific to barriers for preemptive transplant (inadequate social support, gaps in knowledge, and institutional and systemic policies). The results also include various subthemes and the application of these themes to the social ecological model. Conclusions These findings suggest that increasing social support and patient agency, such as through patient navigator programs and encouraging effective communication between health care providers and patients, can facilitate the transplant process. Increasing dissemination of transplant knowledge from institutions and systems to patients through paired kidney exchange education and live donor outreach can also increase timely access to preemptive kidney transplants for patients with ADPKD. Our findings are limited by our single site study in the US, which may not apply to individuals experiencing different social, cultural, and health access conditions. |
| ArticleNumber | 119 |
| Audience | Academic |
| Author | Smith, Juliana Park, Meyeon Harris, Orlando O. Adey, Deborah |
| Author_xml | – sequence: 1 givenname: Juliana surname: Smith fullname: Smith, Juliana organization: University of California, San Francisco School of Medicine – sequence: 2 givenname: Orlando O. surname: Harris fullname: Harris, Orlando O. organization: Department of Community Health Systems, School of Nursing, University of California – sequence: 3 givenname: Deborah surname: Adey fullname: Adey, Deborah organization: Department of Medicine, Division of Nephrology, University of California, San Francisco – sequence: 4 givenname: Meyeon surname: Park fullname: Park, Meyeon email: Meyeon.park@ucsf.edu organization: Department of Medicine, Division of Nephrology, University of California, San Francisco |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37127564$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kktv1DAUhSNURB_wB1ggS2zYpNiJX2GDhopHpUpsYG05zs2MS8ZO7cyg2fHTuTPT0k6FKi8SO985yTm5p8VRiAGK4jWj54xp-T6zSuuqpFVd0popXspnxQnjipVVLZujB_fHxWnO15QypTl9URzXilVKSH5S_PlkU_KQMrGhI711fvCTnSIeTJFMCyBTsiGPgw0TGVN0kBFdxjAno508hCmTwa897n_7aUHGOGzcJk_ekV--C7Ahnc9gM3wgltys7M7dr4HMRnSzbvGyeN7bIcOr2-tZ8fPL5x8X38qr718vL2ZXpZNUTyW0PehOCEd5JxqJ8RmHGjomnADNaN04zbteciU4Bmu2HAje1syqmjNenxWXe98u2mszJr-0aWOi9WZ3ENPc2ISfPYCpaNMKaDplFeUgdds5VlPGWglYHBXo9XHvNa7aJXQOW0h2ODA9fBL8wszj2jDKBJVy6_Du1iHFmxXkySx9djBgzRBX2VSaaoGr0Yi-fYRex1UK2BVSTCCjtLqn5hYT-NBHfLHbmpqZ4gpbkapB6vw_FK4Olt7hdPUezw8Ebx4m_RfxboAQ0HvApZhzgt643R-O2-B-wMRmO6tmP6sGZ9XsZtVIlFaPpHfuT4rqvSgjHOaQ7tt4QvUXBVr7lw |
| CitedBy_id | crossref_primary_10_35366_119984 crossref_primary_10_1097_MOT_0000000000001190 crossref_primary_10_1159_000546881 |
| Cites_doi | 10.1097/TP.0000000000000357 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G 10.5500/wjt.v11.i4.88 10.1038/ki.2015.59 10.1097/01.NNR.0000313482.33917.7d 10.1038/ki.2015.28 10.1191/1478088706qp063oa 10.1186/s12913-020-4974-4 10.1097/TXD.0000000000000773 10.1016/j.amjsurg.2020.09.028 10.1093/ndt/gfu188 10.1097/MNH.0b013e32833e04f5 10.2147/CEOR.S75523 10.1016/j.transproceed.2010.02.031 10.1097/01.asn.0000013295.11876.c9 10.1037/0003-066X.32.7.513 |
| ContentType | Journal Article |
| Copyright | This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 – notice: 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
| DOI | 10.1186/s12882-023-03174-6 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Proquest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: ProQuest Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Education |
| EISSN | 1471-2369 |
| EndPage | 11 |
| ExternalDocumentID | oai_doaj_org_article_209b5e9d7a704e68bdc13011b6e37105 PMC10150665 A747754679 37127564 10_1186_s12882_023_03174_6 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United States United States--US San Francisco California California |
| GeographicLocations_xml | – name: United States – name: San Francisco California – name: United States--US – name: California |
| GrantInformation_xml | – fundername: University of California, San Francisco PKD Center of Excellence grantid: n/a – fundername: NIMH NIH HHS grantid: K23 MH130250 – fundername: ; grantid: n/a |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABUWG ACGFO ACGFS ACIHN ACPRK ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB AAYXX AFFHD CITATION -A0 3V. ACRMQ ADINQ ALIPV C24 CGR CUY CVF ECM EIF NPM 7QP 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI 7X8 5PM |
| ID | FETCH-LOGICAL-c608t-ebfe8d55c04d59618614e3ed15c5e81039c84df647545649c04de54b31a734143 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 2 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000979845700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1471-2369 |
| IngestDate | Fri Oct 03 12:52:42 EDT 2025 Tue Nov 04 02:06:44 EST 2025 Sun Nov 09 10:30:42 EST 2025 Thu Oct 09 22:10:33 EDT 2025 Tue Nov 11 10:23:44 EST 2025 Tue Nov 04 17:22:38 EST 2025 Thu Jan 02 22:41:20 EST 2025 Tue Nov 18 22:43:03 EST 2025 Sat Nov 29 03:42:18 EST 2025 Sat Sep 06 07:22:11 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | PKD ADPKD Preemptive transplant Transplant patient perspective Kidney transplant Polycystic kidney disease |
| Language | English |
| License | 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c608t-ebfe8d55c04d59618614e3ed15c5e81039c84df647545649c04de54b31a734143 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doaj.org/article/209b5e9d7a704e68bdc13011b6e37105 |
| PMID | 37127564 |
| PQID | 2815589787 |
| PQPubID | 44769 |
| PageCount | 11 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_209b5e9d7a704e68bdc13011b6e37105 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10150665 proquest_miscellaneous_2808585898 proquest_journals_2815589787 gale_infotracmisc_A747754679 gale_infotracacademiconefile_A747754679 pubmed_primary_37127564 crossref_citationtrail_10_1186_s12882_023_03174_6 crossref_primary_10_1186_s12882_023_03174_6 springer_journals_10_1186_s12882_023_03174_6 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-05-01 |
| PublicationDateYYYYMMDD | 2023-05-01 |
| PublicationDate_xml | – month: 05 year: 2023 text: 2023-05-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC nephrology |
| PublicationTitleAbbrev | BMC Nephrol |
| PublicationTitleAlternate | BMC Nephrol |
| PublicationYear | 2023 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | M Sandelowski (3174_CR10) 2000; 23 V Braun (3174_CR14) 2006; 3 U Bronfenbrenner (3174_CR17) 1977; 32 C Marshall (3174_CR11) 2006 BM Miles (3174_CR13) 1994 L Burla (3174_CR16) 2008; 57 3174_CR1 3174_CR2 3174_CR4 3174_CR18 3174_CR6 R Krueger (3174_CR12) 2015 3174_CR19 3174_CR8 3174_CR9 3174_CR20 RA Helmick (3174_CR7) 2018; 4 3174_CR21 AB Chapman (3174_CR3) 2015; 88 D van Dellen (3174_CR5) 2021; 11 M Patton (3174_CR15) 2002 |
| References_xml | – ident: 3174_CR9 doi: 10.1097/TP.0000000000000357 – volume: 23 start-page: 334 year: 2000 ident: 3174_CR10 publication-title: Res Nurs Health doi: 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G – volume: 11 start-page: 88 issue: 4 year: 2021 ident: 3174_CR5 publication-title: World J Transplant doi: 10.5500/wjt.v11.i4.88 – volume: 88 start-page: 17 issue: 1 year: 2015 ident: 3174_CR3 publication-title: Kidney Int doi: 10.1038/ki.2015.59 – volume-title: Qualitative research and evaluation methods year: 2002 ident: 3174_CR15 – volume-title: Focus groups: a practical guide for applied research year: 2015 ident: 3174_CR12 – volume: 57 start-page: 113 year: 2008 ident: 3174_CR16 publication-title: Nurs Res doi: 10.1097/01.NNR.0000313482.33917.7d – ident: 3174_CR4 doi: 10.1038/ki.2015.28 – volume: 3 start-page: 77 year: 2006 ident: 3174_CR14 publication-title: Qualitative Res Psychol doi: 10.1191/1478088706qp063oa – ident: 3174_CR2 doi: 10.1186/s12913-020-4974-4 – volume: 4 start-page: e356 issue: 4 year: 2018 ident: 3174_CR7 publication-title: Transpl Direct doi: 10.1097/TXD.0000000000000773 – volume-title: An expanded sourcebook: qualitative data analysis year: 1994 ident: 3174_CR13 – ident: 3174_CR1 doi: 10.1016/j.amjsurg.2020.09.028 – ident: 3174_CR19 doi: 10.1093/ndt/gfu188 – ident: 3174_CR20 doi: 10.1097/MNH.0b013e32833e04f5 – ident: 3174_CR21 doi: 10.1038/ki.2015.59 – ident: 3174_CR6 doi: 10.2147/CEOR.S75523 – ident: 3174_CR8 doi: 10.1016/j.transproceed.2010.02.031 – volume-title: Designing qualitative research year: 2006 ident: 3174_CR11 – ident: 3174_CR18 doi: 10.1097/01.asn.0000013295.11876.c9 – volume: 32 start-page: 513 issue: 7 year: 1977 ident: 3174_CR17 publication-title: Am Psychol doi: 10.1037/0003-066X.32.7.513 |
| SSID | ssj0017840 |
| Score | 2.3175106 |
| Snippet | Background
Kidney transplant is the gold standard for renal replacement therapy in patients with autosomal dominant polycystic kidney disease (ADPKD), which is... Kidney transplant is the gold standard for renal replacement therapy in patients with autosomal dominant polycystic kidney disease (ADPKD), which is the fourth... Background Kidney transplant is the gold standard for renal replacement therapy in patients with autosomal dominant polycystic kidney disease (ADPKD), which is... BackgroundKidney transplant is the gold standard for renal replacement therapy in patients with autosomal dominant polycystic kidney disease (ADPKD), which is... Abstract Background Kidney transplant is the gold standard for renal replacement therapy in patients with autosomal dominant polycystic kidney disease (ADPKD),... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 119 |
| SubjectTerms | ADPKD Adult Care and treatment Consent Costs Data collection Diagnosis Dialysis Education Hemodialysis Humans Internal Medicine Interviews Kidney diseases Kidney Failure, Chronic - etiology Kidney transplant Kidney transplantation Kidney Transplantation - adverse effects Kidney transplants Kidneys Medicine Medicine & Public Health Nephrology Patients PKD Polycystic kidney Polycystic kidney disease Polycystic Kidney Diseases - complications Polycystic Kidney, Autosomal Dominant - complications Preemptive transplant Questionnaires Renal Dialysis - adverse effects Renal failure Renal replacement therapy Renal Replacement Therapy - adverse effects Social interactions Software Transplant patient perspective Transplantation |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwEB5BFyEuPJZXYEFGQuIA0ebhV7igFu2KA1QrBGhvVuK4UFElpeki9cZPZ8Zxu2QRe-Ea25Innqdn_A3A81xhzMVFEgtVzjBAcUVcyYpeo6GUo8lWie91-OW9mk716WlxEi7culBWudWJXlHXraU78sNMo-XTGPOoN8sfMXWNouxqaKFxFfYIqYyPYG9yND35uMsjKIxftk9ltDzsUBujR4l2KkZmVjyWA3PkUfv_1s1_GKeLhZMXsqfeKB3f-l9ybsPN4I6ycc8_d-CKa_apk3Oo-tiH6x9C8v0u_JqUK-pv17GyqdmstD3Ad4sf1i1DR5KtPVL6Ag-LLfsHCMw3M2IBvbVjizldYDC6_WXLdrGxG8KJZt_ndeM2LGSLXrOS9Y89PSo5Gwfc83vw-fjo09t3cWjgEFuZ6HXsqpnTtRA24bWg1jLoC7jc1amwwmlKQlvN65nkivw4XtA8J3iVp6VC68rz-zBq2sY9BJZLWWJsWGlha56i25pIxyvrsiQrMMatIki352hsQDenJhsL46McLU1_9gbP3vizNzKCl7s1yx7b49LZE2KP3UzC5fYf2tVXE8TcZElRCVfUqlQJd1JXtU1JhVbS5ejLiQheEHMZ0h64PVuGRxBIJOFwmTFGd_gzpCoiOBjMRKm3w-EtX5mgdTpzzlQRPNsN00qqpGtce0ZzEkoF60JH8KDn5h1JuEXqBsAj0AM-H9A8HGnm3zwmeeqhKiUS-GorEuf7-vdPfXQ5GY_hRuaFlQpMD2C0Xp25J3DN_lzPu9XTIOy_ARFuWyU priority: 102 providerName: ProQuest – databaseName: Springer Standard Collection dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zi9RAEC50FdkXb9foKi0IPmjYHH3Ft1lx8UEX8Vj2rUk6PTo4JMMkK8ybP92qTmc06wH6mq6GPupMdX0F8DhXGHNxkcRClXMMUFwRV7KiajSUcjTZKvG9Dk9eq-NjfXpavA1FYd342n1MSXpN7cVay4MONSl6g2hjYmRExWN5ES6hudMkju_en2xzBwpjlrE85rfzJibII_X_qo9_MkjnH0uey5h6Q3R07f-2cB2uBseTzQZOuQEXXHMTrrwJqfVb8O2wXFP3uo6VTc3mpR3gu1v80LcM3UTWexz0JV4FWw3lBcy3KmIBm7VjywX9nmD0b5et2uXGbggFmn1Z1I3bsJALes5KNpRyesxxNguo5rfh49HLDy9exaE9Q2xlovvYVXOnayFswmtBjWPQ0rvc1amwwmlKMVvN67nkirw0XhCdE7zK01Kh7eT5Hdhp2sbdBZZLWWLkV2lha56iU5pIxyvrsiQrMIKtIkjHGzM2YJdTC42l8TGMlmY4WoNHa_zRGhnB0-2c1YDc8VfqQ2KELSWhbvsP7fqTCUJssqSohCtqVaqEO6mr2qakICvpcvTURARPiI0M6QZcni1DiQNuklC2zAxjNzwMqYoI9ieUKNN2Ojwyogk6pTOZRt9PY9SvIni0HaaZ9E6uce0Z0SSU6NWFjmBv4NvtlnCJhPXPI9ATjp7seTrSLD57xPHUA1FK3OCzkbF_rOvPh3rv38jvw27mZYOek-7DTr8-cw_gsv3aL7r1Qy_k3wHC1EwE priority: 102 providerName: Springer Nature |
| Title | Barriers and facilitators to the transplant process among patients living with polycystic kidney disease: a qualitative Approach |
| URI | https://link.springer.com/article/10.1186/s12882-023-03174-6 https://www.ncbi.nlm.nih.gov/pubmed/37127564 https://www.proquest.com/docview/2815589787 https://www.proquest.com/docview/2808585898 https://pubmed.ncbi.nlm.nih.gov/PMC10150665 https://doaj.org/article/209b5e9d7a704e68bdc13011b6e37105 |
| Volume | 24 |
| WOSCitedRecordID | wos000979845700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 1471-2369 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017840 issn: 1471-2369 databaseCode: RBZ dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1471-2369 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017840 issn: 1471-2369 databaseCode: DOA dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1471-2369 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017840 issn: 1471-2369 databaseCode: M~E dateStart: 20000101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1471-2369 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017840 issn: 1471-2369 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1471-2369 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017840 issn: 1471-2369 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content Database customDbUrl: eissn: 1471-2369 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017840 issn: 1471-2369 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLink customDbUrl: eissn: 1471-2369 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017840 issn: 1471-2369 databaseCode: RSV dateStart: 20001201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEB_0FPFF_LZ6LhEEH7TYbtMk9W1X7lDwluXUY30KbZrFxaVdtj1h3_zTnUnT9XqivvhSaDOFZDKTmckkvwF4nkiMuXgahanMlxig2CwsREG30VDL0WTLyNU6PPsgZzO1WGTzC6W-6ExYBw_cMQ6D86xIbVbKXEbcClWUJiahLIRN0Do69FL0evpgyucPJMYt_RUZJV43uAqjJ4n2KUQhljwUAzPk0Pp_X5MvGKXLByYvZU2dMTq-Dbe8F8kmXe_vwBVb3YUbJz5Pfg9-TPMtlaJrWF6VbJmbDou7xg9tzdDnY60DNV8jX9mmuyvAXN0h5oFWG7Ze0V4Do41atqnXO7MjSGf2bVVWdsd8YucNy1l3L9MBiLOJhyi_D5-Pjz69fRf6WguhEZFqQ1ssrSrT1ES8TKkKDJptm9gyTk1qFeWLjeLlUnBJLhfPiM6mvEjiXKIh5MkDOKjqyj4ClgiRYxhXqNSUPEYPMxKWF8aOo3GG4WgRQNyzXhsPRE71MNbaBSRK6G66NE6XdtOlRQAv9_9sOhiOv1JPaUb3lASh7T6gYGkvWPpfghXAC5IHTYqO3TO5v6-AgyTILD3BQAyZIWQWwOGAEhXUDJt7idJ-gWj0WKEjpzCElwE82zfTn3TorbL1OdFElLVVmQrgYSeA-yFhFwm4nwegBqI5GPOwpVp9dfDhsUOVFDjAV70U_-rXn5n6-H8w9QncHDstpBOjh3DQbs_tU7huvrerZjuCq3Ih3VON4Nr0aDY_HTm9xrf5-5P5F3w7_Xj2E-yATUY |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3Nb9MwFLdGh4ALH-MrMMBIIA4QLU0c20FCqAOmVWurHgYaJ5M4LlRUSWk6UG_8RfyNvOc4HRlitx24xk5kO-_T773fI-RJJMDnYnHgxyKdgINiEj_jGVajAZeDyhaB7XX4YSBGI3l0lIw3yK-mFgbTKhuZaAV1Xmq8I98JJWg-CT6PeD3_5mPXKIyuNi00arI4MKsf4LJVr_pv4f8-DcO9d4dv9n3XVcDXPJBL32QTI_M41gHLY-x3AgrKRCbvxjo2EiOjWrJ8wplA44IlOM_ELIu6qQCRzyL47gWyyYDYZYdsjvvD8cd13EKAv9SU5ki-U4H0BwsW9KIPzCOYz1vqz3YJ-FsX_KEMTydqnorWWiW4d-1_O77r5Kozt2mv5o8bZMMUW9ip2mW1bJFLQ5dccJP83E0X2L-vommR00mqawDzEh4sSwqGMl1aJPgZECOd1wUW1DZrog6dtqKzKV7QULzdpvNyttIrxMGmX6d5YVbURcNe0pTWxawWdZ32HK77LfL-XM7iNukUZWHuEhpxnoLvm8lY56wLZnnADcu0CYMwAR8-80i3oRulHXo7NhGZKevFSa5qWlNAa8rSmuIeeb5-Z15jl5w5exfJcT0Tccftg3LxWTkxpsIgyWKT5CIVATNcZrnuoorIuInAVo098gyJWaF0hOXp1BV5wCYRZ0z1wHuFw-Ai8ch2ayZINd0ebuhYOalaqRMi9sjj9TC-iZmChSmPcU6AoW6ZSI_cqblnvSVYInY7YB6RLb5q7bk9Uky_WMz1roXi5LDBFw0Lnqzr34d67-xtPCKX9w-HAzXojw7ukyuhFRSYTLtNOsvFsXlALurvy2m1eOgEDSWfzps5fwPp07Xh |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9RAEB-0SumL363RqisIPmhoctmv-HZVD8V6FNTStyXZ7OnhkRyXVLg3_3RnNsnZ1A8QX7OzsB_zmdn5DcCTRGHMxUUUCpXNMEBxaZjLnKrRUMrRZKvI9zo8OVLTqT49TY_PVfH71-59SrKtaSCUprI5WBazVsS1PKhRq6JniPYmRKZUPJSX4QqnpkEUr3842eQRFMYvfanMb-cNzJFH7f9VN58zThcfTl7InnqjNLn-_9u5Adc6h5SNWw66CZdceQu233cp99vw_TBbUVe7mmVlwWaZbWG9K_zQVAzdR9Z4fPQFXhFbtmUHzLcwYh1ma80Wc_ptweifL1tWi7VdEzo0-zovSrdmXY7oBctYW-LpscjZuEM7vwOfJq8_vnwTdm0bQisj3YQunzldCGEjXghqKIMegEtcEQsrnKbUs9W8mEmuyHvjKdE5wfMkzhTaVJ7swlZZle4usETKDCPCXAtb8Bid1Ug6nls3ikYpRrZ5AHF_e8Z2mObUWmNhfGyjpWmP1uDRGn-0RgbwbDNn2SJ6_JX6kJhiQ0lo3P5DtfpsOuE2oyjNhUsLlamIO6nzwsakOHPpEvTgRABPiaUM6Qxcns260gfcJKFvmTHGdHgYUqUB7A8oUdbtcLhnStPpmtqMNPqEOkXNG8DjzTDNpPdzpavOiCaiBLBOdQB7LQ9vtoRLpB4APAA94O7Bnocj5fyLRyKPPUClxA0-75n857r-fKj3_o38EWwfv5qYo7fTd_dhZ-TFhF6c7sNWszpzD-Cq_dbM69VDL_s_ACEJV8w |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Barriers+and+facilitators+to+the+transplant+process+among+patients+living+with+polycystic+kidney+disease%3A+a+qualitative+Approach&rft.jtitle=BMC+nephrology&rft.au=Juliana+Smith&rft.au=Orlando+O.+Harris&rft.au=Deborah+Adey&rft.au=Meyeon+Park&rft.date=2023-05-01&rft.pub=BMC&rft.eissn=1471-2369&rft.volume=24&rft.issue=1&rft.spage=1&rft.epage=11&rft_id=info:doi/10.1186%2Fs12882-023-03174-6&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_209b5e9d7a704e68bdc13011b6e37105 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2369&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2369&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2369&client=summon |